Heart failure & cardiomyopathiesCohort study

Cardiac disease in patients with inflammatory myopathy

ESC Heart FailPublished

  • observational study

Authors' conclusion

Cardiac symptoms, risk factors, and structural abnormalities are prevalent in a substantial proportion of patients with IM. Routine cardiologic assessment, including echocardiography, may be advisable. Further evidence from prospective longitudinal studies is needed to optimize screening algorithms and multidisciplinary management.

Study context

Population
Adult IM patients recruited from the rheumatology outpatient clinic at Ludwig-Maximilians-University Hospital between August 2023 and January 2025adult IM patients who completed a questionnaire
Participants
37 patients
Outcome
Incidence of cardiomyopathy, documented cardiac arrhythmias, and myocardial infarction following the diagnosis of IM

Main finding

As reported in the abstract

Supraventricular arrhythmias documented

10.8%

Ventricular arrhythmias documented

5.4%

Observational data: associations, not effects.

Further findings

Demographics · last follow-up

Median age at last follow-up
60 years
Male
35.1%

Cardiac symptoms reported by study participants

Dyspnoea
45.9%
Congestion/oedema
40.5%
Palpitations
32.4%
Chest pain
18.9%

Arterial hypertension diagnosed after IM had been established

Arterial hypertension
27%

Echocardiography findings

Left ventricular diastolic dysfunction
35.1%
Severe valvular disease documented only in isolated cases of IM
  • Echocardiography was performed in all study participants

Original publication

Cardiac disease in patients with inflammatory myopathy. ESC Heart Fail. Published 13 January 2026. doi:10.1093/eschf/xvag019

Summarised from the published abstract; every number is checked against it